TARS logo

Tarsus Pharmaceuticals (TARS) Company Overview

Profile

Full Name:

Tarsus Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 16, 2020

Indexes:

Not included

Description:

Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing innovative treatments for eye diseases. They aim to improve patient outcomes through advanced therapies, particularly for conditions like dry eye disease. Their research combines science and technology to create effective solutions for vision-related health issues.

Key Details

Price

$47.50

Annual Revenue

$182.95 M(+948.62% YoY)

Annual EPS

-$3.07(+33.55% YoY)

Annual ROE

-54.83%

Beta

0.78

Events Calendar

Earnings

Next earnings date:

May 8, 2025

Recent quarterly earnings:

Feb 25, 2025

Recent annual earnings:

Feb 25, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 26, 25 HC Wainwright & Co.
Buy
Feb 26, 25 Guggenheim
Buy
Feb 26, 25 Barclays
Overweight
Feb 24, 25 Guggenheim
Buy
Feb 10, 25 Guggenheim
Buy
Jan 27, 25 Barclays
Overweight
Jan 22, 25 Oppenheimer
Outperform
Nov 15, 24 Goldman Sachs
Neutral
Nov 14, 24 Oppenheimer
Outperform
Aug 9, 24 Oppenheimer
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Tarsus Pharmaceuticals?
  • Does Tarsus Pharmaceuticals pay dividends?
  • What sector is Tarsus Pharmaceuticals in?
  • What industry is Tarsus Pharmaceuticals in?
  • What country is Tarsus Pharmaceuticals based in?
  • When did Tarsus Pharmaceuticals go public?
  • Is Tarsus Pharmaceuticals in the S&P 500?
  • Is Tarsus Pharmaceuticals in the NASDAQ 100?
  • Is Tarsus Pharmaceuticals in the Dow Jones?
  • When was Tarsus Pharmaceuticals's last earnings report?
  • When does Tarsus Pharmaceuticals report earnings?
  • Should I buy Tarsus Pharmaceuticals stock now?

What is the ticker symbol for Tarsus Pharmaceuticals?

The ticker symbol for Tarsus Pharmaceuticals is NASDAQ:TARS

Does Tarsus Pharmaceuticals pay dividends?

No, Tarsus Pharmaceuticals does not pay dividends

What sector is Tarsus Pharmaceuticals in?

Tarsus Pharmaceuticals is in the Healthcare sector

What industry is Tarsus Pharmaceuticals in?

Tarsus Pharmaceuticals is in the Biotechnology industry

What country is Tarsus Pharmaceuticals based in?

Tarsus Pharmaceuticals is headquartered in United States

When did Tarsus Pharmaceuticals go public?

Tarsus Pharmaceuticals's initial public offering (IPO) was on October 16, 2020

Is Tarsus Pharmaceuticals in the S&P 500?

No, Tarsus Pharmaceuticals is not included in the S&P 500 index

Is Tarsus Pharmaceuticals in the NASDAQ 100?

No, Tarsus Pharmaceuticals is not included in the NASDAQ 100 index

Is Tarsus Pharmaceuticals in the Dow Jones?

No, Tarsus Pharmaceuticals is not included in the Dow Jones index

When was Tarsus Pharmaceuticals's last earnings report?

Tarsus Pharmaceuticals's most recent earnings report was on Feb 25, 2025

When does Tarsus Pharmaceuticals report earnings?

The next expected earnings date for Tarsus Pharmaceuticals is May 8, 2025

Should I buy Tarsus Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions